Press release
Investigation announced for Investors in shares of Clariant AG (OTC: CLZNY)
An investigation for investors in Clariant AG (OTC: CLZNY) shares over potential securities laws violations by Clariant AG.
Investors who purchased shares of Clariant AG (OTC: CLZNY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Clariant AG (OTC: CLZNY) concerning whether a series of statements by Clariant AG regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Switzerland based Clariant AG, together with its subsidiaries, develops, manufactures, distributes, and sells specialty chemicals worldwide. Clariant AG reported that its annual Total Revenue declined from over $4.39 billion in 2019 to over $3.86 billion in 2020, and that its Net Income increased from $10 million in 2019 to $758 million in 2020.
On February 14, 2022, Clariant AG disclosed that it would delay the release of its fourth quarter and full year 2021 financial results due to an internal "investigation into accounting matters related to the booking of provisions and accruals during the financial years 2020 and 2021." Specifically, the investigation "is reviewing whether employees incorrectly booked those provisions and accruals, with the aim of steering the Company's results to meet internal and external targets."
Shares of Clariant AG (OTC: CLZNY) declined from $21.49 per share in January 2022, to as low as $14.89 per share on March 8, 2022.
Those who purchased shares of Clariant AG (OTC: CLZNY) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Clariant AG (OTC: CLZNY) here
News-ID: 2578211 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Clariant
Troy Corporation ThorGmbh Lanxess Clariant BASF AkzoNobel
Global Microbial Control market size will increase to Million US$ by 2025, from Million US$ in 2017, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Microbial Control.
This report researches the worldwide Microbial Control market size (value, capacity, production and consumption) in key regions like North…
Clariant successfully issues EUR 500 million Eurobond
Muttenz, January 17, 2012 – Today, Clariant successfully priced an Eurobond transaction of EUR 500 million with a tenor of 5 years, issued by Clariant Finance (Luxembourg) S.A. and guaranteed by Clariant Ltd.
The fixed rate notes with a minimum denomination of EUR 100,000 and a final coupon of 5 ⅝ % p.a. are maturing on January 24, 2017. The orderbook was significantly oversubscribed on the back of strong investor demand.…
Clariant strengthens Asian presence
New Singapore Headquarters for South East Asia & Pacific
New Textile Chemicals Headquarters and application lab
First Asian Clariant ethoxylation plant in Dayabay, China
Muttenz/Singapore, November 1, 2011 - The Swiss-based specialty chemicals company Clariant announces the opening of its new Regional Headquarters for South East Asia & Pacific and its new Global Textile Chemicals headquarters, both located in Singapore. Today Clariant is also celebrating the inauguration of its newly built ethoxylation plant…
Clariant acquires Oberhausen Technology Center (OTC)
Acquisition is part of company strategy to develop and strengthen ICS portfolio
Clariant gains technological expertise in new formulation technologies and delivery systems to serve customer needs in the consumer care market
Muttenz, October 26, 2011 – The Swiss specialty chemicals group Clariant has acquired German company Oberhausen Technology Center (OTC) to further strengthen its Industrial & Consumer Specialties Business Unit (ICS). Financial details of the acquisition are not being disclosed. The…
Clariant sells its Polysilazane coatings business
Muttenz, 4 October 2011 – Clariant, a world leader in specialty chemicals, today announced the sale of its Polysilazane coatings business including the production site in India to AZ Electronic Materials (AZ) for a consideration of approximately EUR 4 million.
Under the terms of the agreement, Clariant retains the exclusive right to develop and use Polysilazanes for composite materials and ceramics. Clariant will continue its development in the area of…
Clariant further expands operating margin
• Sales up 5% in local currencies on price increases, down 6% in CHF
• EBITDA margin before exceptional items at 16.1% compared to 12.9% in the previous year
• EBIT margin before exceptional items rose to 13.4% from 10.1% in Q1 2010
• Positive cash flow from operations of CHF 17 million
• Net income of CHF 120 million compared to CHF 10 million a year ago
• Süd-Chemie acquisition closed, integration process initiated; consolidation
as of 21 April…
